Marc Bonten to Cost-Benefit Analysis
This is a "connection" page, showing publications Marc Bonten has written about Cost-Benefit Analysis.
Connection Strength
0.110
-
[A trial to study the effect of influenza vaccination in the elderly: ethical, feasible and badly needed]. Ned Tijdschr Geneeskd. 2018 09 06; 162.
Score: 0.090
-
Cost-effectiveness of antibiotic treatment strategies for community-acquired pneumonia: results from a cluster randomized cross-over trial. BMC Infect Dis. 2017 01 10; 17(1):52.
Score: 0.020